<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="article-commentary" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Neurogenesis (Austin)</journal-id>
<journal-id journal-id-type="iso-abbrev">Neurogenesis (Austin)</journal-id>
<journal-id journal-id-type="publisher-id">KNGS</journal-id>
<journal-id journal-id-type="publisher-id">kngs20</journal-id>
<journal-title-group>
<journal-title>Neurogenesis</journal-title>
</journal-title-group>
<issn pub-type="epub">2326-2133</issn>
<publisher>
<publisher-name>Taylor &amp; Francis</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28229087</article-id>
<article-id pub-id-type="pmc">5305168</article-id>
<article-id pub-id-type="publisher-id">1283187</article-id>
<article-id pub-id-type="doi">10.1080/23262133.2017.1283187</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Commentary</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Modeling Williams syndrome with induced pluripotent stem cells</article-title>
<alt-title alt-title-type="running-authors">T. CHAILANGKARN AND A. R. MUOTRI</alt-title>
<alt-title alt-title-type="running-title">NEUROGENESIS</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Chailangkarn</surname>
<given-names>Thanathom</given-names>
</name>
<xref ref-type="aff" rid="af0001">
<sup>a</sup>
</xref>
<xref ref-type="aff" rid="af0002">
<sup>b</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Muotri</surname>
<given-names>Alysson R.</given-names>
</name>
<xref ref-type="aff" rid="af0001">
<sup>a</sup>
</xref>
<xref ref-type="corresp" rid="an0001"></xref>
</contrib>
<aff id="af0001"><label>a</label><institution>University of California San Diego, School of Medicine, Department of Pediatrics/Rady Children's Hospital San Diego, Department of Cellular &amp; Molecular Medicine, Stem Cell Program, Center for Academic Research and Training in Anthropogeny (CARTA)</institution>, La Jolla, CA, <country>USA</country></aff>
<aff id="af0002"><label>b</label><institution>National Center for Genetic Engineering and Biotechnology (BIOTEC), Virology and Cell Technology Laboratory</institution>, Pathum Thani, <country>Thailand</country></aff>
</contrib-group>
<author-notes>
<corresp id="an0001"><bold>CONTACT</bold> Alysson R. Muotri <email xlink:href="muotri@ucsd.edu">muotri@ucsd.edu</email><addr-line>2880 Torrey Pines Scenic Drive</addr-line>, La Jolla, CA 92037, <country>USA</country></corresp>
</author-notes>
<pub-date pub-type="collection">
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>6</day>
<month>2</month>
<year>2017</year>
</pub-date>
<volume>4</volume>
<issue>1</issue>
<elocation-id seq="1">e1283187</elocation-id>
<history>
<date date-type="received">
<day>3</day>
<month>10</month>
<year>2016</year>
</date>
<date date-type="rev-recd">
<day>1</day>
<month>12</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>10</day>
<month>1</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>© 2017 Taylor &amp; Francis</copyright-statement>
<copyright-year>2017</copyright-year>
<copyright-holder>Taylor &amp; Francis</copyright-holder>
</permissions>
<self-uri content-type="pdf" xlink:href="kngs-04-01-1283187.pdf"></self-uri>
<abstract>
<title>ABSTRACT</title>
<p>The development of induced pluripotent stem cells (iPSCs) like never before has opened novel opportunity to study diseases in relevant cell types. In our recent study, Williams syndrome (WS), a rare genetic neurodevelopmental disorder, that is caused by hemizygous deletion of 25–28 genes on chromosome 7, is of interest because of its unique cognitive and social profiles. Little is known about haploinsufficiency effect of those deleted genes on molecular and cellular phenotypes at the neural level due to the lack of relevant human cellular model. Using the cellular reprogramming approach, we reported that WS iPSC-derived neural progenitor cells (NPCs) has increased apoptosis and therefore increased doubling time, which could be rescued by complementation of frizzled 9, one of the genes typically deleted in WS. Moreover, WS iPSC-derived CTIP2-positive pyramidal neurons exhibit morphologic alterations including longer total dendrites and increasing dendritic spine number. In addition, WS iPSC-derived neurons show an increase in calcium transient frequency and synchronized activity likely due to increased number of dendritic spines and synapses. Our work integrated cross-level data from genetics to behavior of WS individuals and revealed altered cellular phenotypes in WS human NPCs and neurons that could be validated in other model systems such as magnetic resonance imaging (MRI) in live subjects and postmortem brain tissues.</p>
</abstract>
<kwd-group kwd-group-type="author">
<title>KEYWORDS</title>
<kwd>disease modeling</kwd>
<kwd>iPSC</kwd>
<kwd>Williams syndrome</kwd>
</kwd-group>
<counts>
<fig-count count="2"></fig-count>
<table-count count="1"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="61"></ref-count>
<page-count count="9"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>